Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Discontinuing GLP-1 medications safely
indicated that, in patients with T2DM, albiglutide did not increase adverse AF events and was instead associated with a trend toward reduced AF incidence during follow-up, although this relationship did not achieve statistical significance (135)
Ge C, Spnning E, Glaser E, Wieslander A
Molecular Genetics and Metabolism
Future research should aim to clarify the GLP-1RA-specific benefits and mechanisms in HFpEF, which would help to integrate them more effectively into therapeutic regimens.
/assets/images/provider/photos/2775905.jpeg)
US$ 23.52
US$ 26.43
US$ 25.24
US$ 23.60
US$ 21.99
